NSE filing, NSE: HAVELLS. Summary written from the filing by ALFA Finder's alert engine.
Havells India Ltd: key numbers
- Share price
- ₹1,025.40
- Market cap
- ₹64,287 Cr
- Revenue (annual)
- ₹22,528 Cr
- Net profit (annual)
- ₹1,691 Cr
- P/E (TTM)
- 38.6×Sector 42.1×
- Promoter holding
- 59.35%+0.00% QoQ
- FII holding
- 14.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Havells India Ltd
All →Havells India Management Change
Havells India disclosed that its President, Samir Kirit Anjaria, resigned effective October 27, 2026. The filing attaches his resignation letter.
Havells India Earnings Call Transcript: Key Takeaways
Strong 35% revenue growth masks margin pressure in cables due to raw material volatility and seasonal Lloyd losses.
Havells India Investor Presentation: Key Takeaways
Havells delivered 35% YoY revenue growth in Q2 FY27, driven by strong volumes across segments. EBITDA grew 30.5% despite softer contribution margins in cables due to volatile aluminum prices.
Havells India Q2 FY27 Results: Net Profit ₹349.2 Cr, Up 9.7% YoY
Havells India Ltd reported revenue from operations of ₹6,432 Cr (+34.6% YoY) and net profit of ₹349.2 Cr (+9.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹349.2 Cr · +9.7% YoY
Havells India Capital Structure Change
HDFC Mutual Fund acquired 1,00,127 equity shares of Havells India Ltd via open market, increasing its total shareholding to 5.012%.
Havells India Management Change
Havells India Limited has appointed Mr. Yudhishter Shringi as Executive Vice President & SBU Head, effective 12th October 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.